<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0002079'>Hyperinsulinism</z:mp> in infancy (HI) is a condition of neonates and early childhood </plain></SENT>
<SENT sid="1" pm="."><plain>For many years the pathophysiology of this potentially lethal disorder was unknown </plain></SENT>
<SENT sid="2" pm="."><plain>Advances in the genetics, histopathology and molecular <z:mp ids='MP_0001532'>physiology</z:mp> of this disease have now provided insights into the causes of <z:hpo ids='HP_0006279'>beta-cell dysfunction</z:hpo> and revealed levels of diversity far in excess of our previous knowledge </plain></SENT>
<SENT sid="3" pm="."><plain>These include defects in ion channel subunit genes and mutations in several enzymes associated with beta-cell metabolism and anaplerosis </plain></SENT>
<SENT sid="4" pm="."><plain>In most cases, beta-cell pathophysiology leads to an alteration in the function of ATP-sensitive <z:chebi fb="0" ids="29103">K(+)</z:chebi> channels </plain></SENT>
<SENT sid="5" pm="."><plain>This can manifest as '<z:e sem="disease" ids="C1720983" disease_type="Disease or Syndrome" abbrv="">channelopathies</z:e>' of K(ATP) channels through gene defects in ABCC8 and KCNJ11 (Ch.11p15); or as a result of 'metabolopathies' through defects in the genes encoding glucokinase (GCK, Ch.7p15-p13), <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> dehydrogenase (GLUD1, Ch.10q23.3) and short-chain L-3-hydroxyacyl-CoA dehydrogenase (HADHSC, Ch.4q22-q26) </plain></SENT>
<SENT sid="6" pm="."><plain>This review focuses upon the relationship between the causes of HI and therapeutic options </plain></SENT>
</text></document>